Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#91 / 200 Total
BIMI - BIMI Holdings Inc. - Stock Price Chart
TickerBIMI [NASD]
CompanyBIMI Holdings Inc.
CountryUSA
IndustryPharmaceutical Retailers
Market Cap15.07MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y5.28%
P/S-EPS next 5Y-
P/B1.00EPS Q/Q73.16%
Dividend-Sales Q/Q-48.79%
Insider Own91.93%Inst Own0.15%
Insider Trans-0.04%Inst Trans5.84%
Short Float2.94%EarningsNov 27/b
Analyst Recom-Target Price-
Avg Volume49.59K52W Range0.80 - 4.13
Apr-23-24 04:05PM BIMI Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq (GlobeNewswire) +17.86%
Jan-03-24 07:00AM BIMI Announces Results of 2023 Annual General Meeting of Stockholders (GlobeNewswire) -7.52%
Dec-19-23 08:01AM BIMI International Medical Inc. Announces Third Quarter 2023 Financial Results (GlobeNewswire) -7.75%
Nov-28-23 08:00AM BIMI Announces Buyback of Warrants (GlobeNewswire) +14.97%
Nov-27-23 08:25AM BIMI Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1) (GlobeNewswire) +33.57%
08:25AM BIMI International Medical Inc. Announces Second Quarter 2023 Financial Results (GlobeNewswire)
Nov-08-23 09:12AM BIMI Announces Subsidiary Phenix Bio Inc.'s New Product Launch (GlobeNewswire)
Oct-30-23 09:29AM BIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc's Appointment of Hong Kong, Taiwan, and Macau Exclusive Distributor (GlobeNewswire)
09:27AM BIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc's Appointment of Mainland China Non-Exclusive Distributor (GlobeNewswire)
Sep-22-23 09:00AM BIMI International Medical Inc. Announces Subsidiary Phenix Bio Incs Appointment of ASEAN Exclusive Distributor (GlobeNewswire)
BNAI - Brand Engagement Network Inc - Stock Price Chart
TickerBNAI [NASD]
CompanyBrand Engagement Network Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap38.32MEPS (ttm)-0.00
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.88EPS Q/Q-422.46%
Dividend-Sales Q/Q-
Insider Own54.73%Inst Own2.48%
Insider Trans0.00%Inst Trans5.83%
Short Float0.11%EarningsMay 14/a
Analyst Recom-Target Price-
Avg Volume105.92K52W Range0.99 - 19.75
May-14-24 09:53PM BNAI Stock Earnings: Brand Engagement Network Reported Results for Q1 2024 (InvestorPlace)
04:15PM BEN Reports First Quarter 2024 Financial Results (Business Wire)
May-09-24 08:00AM BEN Achieves HIPAA Compliance for Healthcare AI Assistants (Business Wire)
May-02-24 09:27AM BEN Announces Date of First Quarter 2024 Financial Results Conference Call (Business Wire) -23.22%
Apr-16-24 08:00AM BEN Partners with OSF HealthCare to Develop AI Solution for Primary Care Training & Patient Evaluation (Business Wire)
Apr-09-24 12:06PM Provana and BEN Sign Partnership to Revolutionize Business Process Management with AI Integration (Business Wire) -10.24%
Mar-14-24 06:48PM BEN Announces Closing of Business Combination, to Begin Trading on Nasdaq Under Symbol "BNAI" (Business Wire) -6.78%
ELDN - Eledon Pharmaceuticals Inc - Stock Price Chart
TickerELDN [NASD]
CompanyEledon Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap72.84MEPS (ttm)-1.49
P/E-EPS this Y31.40%
Forward P/E-EPS next Y44.59%
PEG-EPS past 5Y43.37%
P/S-EPS next 5Y-
P/B1.00EPS Q/Q54.47%
Dividend-Sales Q/Q-
Insider Own5.59%Inst Own36.04%
Insider Trans0.00%Inst Trans-1.35%
Short Float0.15%EarningsMay 09/b
Analyst Recom1.00Target Price14.00
Avg Volume168.52K52W Range1.07 - 2.94
May-14-24 12:00PM Eledon Pharmaceuticals (ELDN) Moves to Buy: Rationale Behind the Upgrade (Zacks) +6.85%
May-09-24 01:54PM ELDN Stock Earnings: Eledon Pharma Beats EPS for Q1 2024 (InvestorPlace)
07:30AM Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results (GlobeNewswire)
07:00AM Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress (GlobeNewswire)
May-07-24 07:05AM Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection (GlobeNewswire) -7.38%
07:00AM Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement (GlobeNewswire)
Mar-28-24 04:01PM Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results (GlobeNewswire)
Mar-25-24 04:56PM Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection (GlobeNewswire)
Mar-21-24 10:31AM Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human (GlobeNewswire) +11.24%
Feb-13-24 07:01PM Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
LINK - Interlink Electronics - Stock Price Chart
TickerLINK [NASD]
CompanyInterlink Electronics
CountryUSA
IndustryElectronic Components
Market Cap52.06MEPS (ttm)-0.12
P/E-EPS this Y-556.25%
Forward P/E-EPS next Y17.14%
PEG-EPS past 5Y-
P/S3.78EPS next 5Y-
P/B4.31EPS Q/Q-190.14%
Dividend-Sales Q/Q-4.70%
Insider Own98.48%Inst Own0.68%
Insider Trans0.00%Inst Trans11.29%
Short Float7.31%EarningsMay 09/b
Analyst Recom1.00Target Price7.00
Avg Volume7.77K52W Range4.25 - 11.49
May-09-24 09:00AM Interlink Electronics Reports First Quarter 2024 Results (PR Newswire)
Mar-27-24 09:02AM LINK Stock Earnings: Interlink Electronics Reported Results for Q4 2023 (InvestorPlace)
Mar-21-24 09:43AM Interlink Electronics Posts Loss In Q4 - Quick Facts (RTT News)
09:00AM Interlink Electronics Reports Fourth Quarter and Fiscal Year 2023 Results (PR Newswire)
Mar-03-24 02:00PM Take Your Profits! 3 High-Flying Tech Stocks to Sell While You Can (InvestorPlace)
Mar-01-24 09:00AM Interlink Electronics Announces 50% Common Stock Dividend (PR Newswire) +11.82%
Feb-29-24 09:00AM Interlink Electronics, Inc. Presenting and Exhibiting at LOPEC 2024 - the world's leading exhibition and conference for flexible, organic, and printed electronics (PR Newswire) -6.48%
Nov-09-23 09:00AM Interlink Electronics Reports Third Quarter 2023 Results (PR Newswire) +5.28%
Oct-09-23 02:29PM Interlink Electronics, Inc. to Present at Maxim Group LLC Virtual Tech Conference Series: Exploring All Corners of the Tech Sector (PR Newswire)
09:55AM Maxim Group LLC to Host the Virtual Tech Conference Series: Exploring All Corners of the Tech Sector, on Tuesday, October 10th & Wednesday, October 11th at 8:30 A.M. E.T. (GlobeNewswire)
BDRX - Biodexa Pharmaceuticals Plc ADR - Stock Price Chart
TickerBDRX [NASD]
CompanyBiodexa Pharmaceuticals Plc ADR
CountryUnited Kingdom
IndustryBiotechnology
Market Cap0.29MEPS (ttm)-19.22
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y86.34%
P/S0.61EPS next 5Y-
P/B3.15EPS Q/Q99.66%
Dividend-Sales Q/Q-61.66%
Insider Own-Inst Own19.88%
Insider Trans-Inst Trans-10.09%
Short Float-EarningsApr 19/b
Analyst Recom1.00Target Price8.00
Avg Volume2.95M52W Range0.67 - 20.39
May-15-24 03:58AM Posting of Annual Report & Notice of AGM - Total Voting Rights (GlobeNewswire)
May-09-24 08:00AM Biodexa Looks To Prevent Or Delay The Worst Outcomes For Adolescents And Young Adults With Devastating Precancerous Condition (ACCESSWIRE)
Apr-30-24 11:52AM Biodexa's Licensor Emtora to Announce Phase 2 Clinical Trial Results of eRapa in Familial Adenomatous Polyposis to be Presented at Prestigious 2024 Digestive Disease Week Annual Meeting (GlobeNewswire) +15.27%
Apr-28-24 12:01PM 12 ChatGPT Penny Stock Picks Right Now (Insider Monkey)
Apr-26-24 03:18PM Why Is Biodexa (BDRX) Up 70% Today? (InvestorPlace) +79.36%
08:30AM Biodexa Enters Into Exclusive License to eRapa , a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP) (GlobeNewswire)
Apr-19-24 08:00AM Preliminary Results for the Year Ended 31 December 2023 (GlobeNewswire) -8.30%
Mar-28-24 11:22AM Why Is Biodexa Pharmaceuticals (BDRX) Stock Up 106% Today? (InvestorPlace) +88.59%
08:15AM Biodexa's MTX110 Shows Promise In Extending Life Expectancy Against Aggressive Brain Cancers (ACCESSWIRE)
Mar-01-24 08:00AM Biodexa Takes Aim At Type 1 Diabetes With Innovative Drug Candidate Tolimidone (ACCESSWIRE) +7.09%
MOGU - MOGU Inc ADR - Stock Price Chart
TickerMOGU [NYSE]
CompanyMOGU Inc ADR
CountryChina
IndustryInternet Retail
Market Cap14.49MEPS (ttm)-2.48
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y32.00%
P/S0.51EPS next 5Y-
P/B0.17EPS Q/Q-286.38%
Dividend-Sales Q/Q-26.34%
Insider Own0.90%Inst Own24.67%
Insider Trans0.00%Inst Trans-6.12%
Short Float0.13%Earnings-
Analyst Recom1.00Target Price29.40
Avg Volume4.25K52W Range1.41 - 2.92
May-14-24 09:00AM MOGU Announces US$8 Million Share Repurchase Program (Business Wire) +13.01%
Dec-18-23 05:51AM MOGU Stock Earnings: MOGU Reported Results for H1 2024 (InvestorPlace)
Dec-15-23 11:00AM MOGU Announces Unaudited Financial Results for the Six Months Ended September 30, 2023 (Business Wire)
Oct-17-23 08:00AM Baijiayun Announces Change in Management (PR Newswire)
Aug-25-23 12:08PM MOGU Inc's Rocky Road Ahead: Unraveling the Factors Limiting Growth (GuruFocus.com) +6.21%
Jul-31-23 04:00PM MOGU Files Annual Report on Form 20-F for Fiscal Year 2023 (Business Wire)
Jul-27-23 07:05AM Getting In Cheap On MOGU Inc. (NYSE:MOGU) Is Unlikely (Simply Wall St.)
Jun-12-23 08:09AM Companies Like MOGU (NYSE:MOGU) Are In A Position To Invest In Growth (Simply Wall St.) +7.53%
Jun-02-23 01:00AM MOGU Announces Unaudited Financial Results For the Six Months Ended March 31, 2023 and Fiscal Year 2023 (Business Wire)
Apr-21-23 05:00PM MOGU Announces Resignation and Appointment of Directors (Business Wire)
KOD - Kodiak Sciences Inc - Stock Price Chart
TickerKOD [NASD, RUT]
CompanyKodiak Sciences Inc
CountryUSA
IndustryBiotechnology
Market Cap174.37MEPS (ttm)-4.44
P/E-EPS this Y26.57%
Forward P/E-EPS next Y-6.05%
PEG-EPS past 5Y-12.42%
P/S-EPS next 5Y12.40%
P/B0.72EPS Q/Q39.40%
Dividend-Sales Q/Q-
Insider Own7.37%Inst Own81.16%
Insider Trans0.00%Inst Trans2.83%
Short Float5.35%EarningsMay 15/a
Analyst Recom4.00Target Price3.50
Avg Volume729.14K52W Range1.37 - 9.80
May-16-24 12:51PM Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus (Zacks)
May-15-24 10:55PM KOD Stock Earnings: Kodiak Sciences Beats EPS for Q1 2024 (InvestorPlace)
04:01PM Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results (PR Newswire)
May-14-24 07:31AM Kodiak Sciences dosing subjects in Phase III trial of diabetic retinopathy drug (Clinical Trials Arena)
May-13-24 07:32PM Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy (PR Newswire) +6.09%
May-02-24 04:30PM Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform (PR Newswire)
Apr-04-24 12:09PM Kodiak (KOD) Counts on Tarcocimab Program Despite Setbacks (Zacks)
Apr-01-24 05:04PM Kodiak Sciences Inc. (NASDAQ:KOD) Q4 2023 Earnings Call Transcript (Insider Monkey) -15.40%
12:00PM Kodiak (KOD) Stock Falls on Q4 Earnings Miss, Pipeline in Focus (Zacks)
Mar-29-24 10:36AM Q4 2023 Kodiak Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
BYSI - BeyondSpring Inc - Stock Price Chart
TickerBYSI [NASD]
CompanyBeyondSpring Inc
CountryUSA
IndustryBiotechnology
Market Cap103.79MEPS (ttm)-0.54
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y25.94%
P/S59.31EPS next 5Y-
P/B-EPS Q/Q52.99%
Dividend-Sales Q/Q87.78%
Insider Own39.17%Inst Own2.38%
Insider Trans0.00%Inst Trans-20.48%
Short Float10.00%Earnings-
Analyst Recom2.00Target Price1.25
Avg Volume214.99K52W Range0.65 - 4.00
May-16-24 08:00AM BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics (GlobeNewswire)
May-03-24 07:00AM BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics (GlobeNewswire)
Apr-29-24 05:30PM BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results (GlobeNewswire)
05:30PM BeyondSpring Files 2023 Annual Report on Form 20-F (GlobeNewswire)
Mar-25-24 07:00AM BeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancer (GlobeNewswire) +11.22%
Feb-26-24 08:00AM BeyondSpring Regains Compliance with Nasdaq Minimum Bid Price and Periodic Filing Requirements (GlobeNewswire) +9.17%
Jan-10-24 03:00PM BeyondSpring Receives Nasdaq Delinquency Notice Regarding Late Filing of Its Form 6-K (GlobeNewswire)
Dec-18-23 04:30PM BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements (GlobeNewswire)
Nov-07-23 07:00AM BeyondSpring Presents Poster Highlighting Preclinical and Clinical POC Immunomodulating Activity of Plinabulin Inducing Dendritic Cell Maturation and Re-sensitization in Immunotherapy Refractory Tumors when Combined with Radiation and PD-1/PD-L1 Inhibitors (GlobeNewswire)
Oct-31-23 08:00AM BeyondSpring and Professor K. Eisenmann of the University of Toledo College of Medicine Present Poster Highlighting Plinabulin's Anti-cancer Efficacy in Primary and Recurrent Glioblastoma Patient Derived Invasive Neurosphere Models (GlobeNewswire)
NRIX - Nurix Therapeutics Inc - Stock Price Chart
TickerNRIX [NASD, RUT]
CompanyNurix Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap965.73MEPS (ttm)-2.65
P/E-EPS this Y-10.55%
Forward P/E-EPS next Y-8.06%
PEG-EPS past 5Y-59.00%
P/S11.94EPS next 5Y-
P/B4.74EPS Q/Q-0.31%
Dividend-Sales Q/Q30.74%
Insider Own6.52%Inst Own80.68%
Insider Trans-0.91%Inst Trans-4.59%
Short Float12.45%EarningsApr 10/b
Analyst Recom1.33Target Price24.67
Avg Volume1.08M52W Range4.22 - 18.12
May-14-24 10:00AM Nurix Therapeutics Announces Upcoming Oral Presentation of New Data from Ongoing Clinical Trial of NX-5948, a Selective Bruton's Tyrosine Kinase (BTK) Degrader, at the European Hematology Association Congress (EHA2024) (GlobeNewswire) +7.25%
07:39AM Stephens Initiates Nurix Therapeutics With Overweight Rating, $20 Price Target (MT Newswires)
May-07-24 07:00AM Nurix Therapeutics to Participate in RBC Capital Markets Global Healthcare Conference (GlobeNewswire) +7.11%
Apr-16-24 06:21PM Nurix Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire) -5.24%
Apr-11-24 11:38PM Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering (GlobeNewswire) +9.69%
04:00PM Nurix Therapeutics Announces Proposed Public Offering (GlobeNewswire)
Apr-10-24 11:53AM NRIX Stock Earnings: Nurix Therapeutics Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace) -10.24%
09:29AM Nurix (NRIX) Up on Upbeat Initial Data From Phase I Cancer Study (Zacks)
08:31AM Nurix Therapeutics Inc (NRIX) Misses Earnings Predictions But Shows Revenue Growth in Q1 Fiscal 2024 (GuruFocus.com)
08:10AM Nurix Therapeutics, Inc. (NRIX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
VUZI - Vuzix Corporation - Stock Price Chart
TickerVUZI [NASD, RUT]
CompanyVuzix Corporation
CountryUSA
IndustryConsumer Electronics
Market Cap92.56MEPS (ttm)-0.78
P/E-EPS this Y43.67%
Forward P/E-EPS next Y-10.11%
PEG-EPS past 5Y1.93%
P/S9.31EPS next 5Y20.00%
P/B1.27EPS Q/Q4.20%
Dividend-Sales Q/Q-52.19%
Insider Own7.36%Inst Own34.18%
Insider Trans1.05%Inst Trans-1.34%
Short Float17.92%EarningsMay 09/a
Analyst Recom2.00Target Price3.00
Avg Volume837.25K52W Range1.10 - 6.06
May-14-24 10:16AM Vuzix Signs Development Contract With Garmin for Display System; Shares Rise (MT Newswires) +11.94%
09:30AM Garmin Collaborates with Vuzix to Develop Next Generation Nano-Imprinted Waveguide with microLED based Display Systems (PR Newswire)
May-10-24 10:24AM Vuzix Corporation (NASDAQ:VUZI) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:00AM Vuzix to Bring New Low Cost, Full Color Waveguides to Display Week 2024 (PR Newswire)
May-09-24 08:58PM VUZI Stock Earnings: Vuzix Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace) -8.59%
04:42PM Vuzix: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM Vuzix Reports First Quarter 2024 Results (PR Newswire)
May-02-24 11:30AM Vuzix Schedules Conference Call to Discuss First Quarter 2024 Financial Results and Business Update (PR Newswire)
May-01-24 03:37PM 3 Tech Stocks to Sell ASAP Before They Collapse (InvestorPlace)
Apr-29-24 09:19AM 3 Augmented Reality Stocks With the Potential to Make You an Overnight Millionaire (InvestorPlace) +6.06%
1⋯56789101112131415⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.